This federal contract award, with ID SPE2DB22D1017|SPE2DB25FF0UX, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,245.83 firm fixed-price delivery order is for the supply of Tresiba FlexTouch insulin pens, a specialty medication used to manage diabetes. The contract has an ultimate completion date of December 10, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Generated 3/16/25, 12:52 AM